Imperial College London Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
University of Reading Featured PhD Programmes
"disease"×
10 miles

disease PhD Projects, Programs & Scholarships

We have 714 disease PhD Projects, Programs & Scholarships

  • "disease" ×
  • clear all
Order by 
Showing 1 to 15 of 714
  Phenotyping placental disease in women with diabetes and chronic hypertension using transcriptomic analysis
  Dr J Myers, Dr E Johnstone
Applications accepted all year round

Funding Type

PhD Type

Placental disease triggers medically-indicated preterm birth in 1 in 6 pregnancies complicated by chronic hypertension and/or diabetes (cardiometabolic disease).
  Disease phenomics - quantifying the development of disease symptoms in infected plants
  Dr S A Rolfe
Applications accepted all year round

Funding Type

PhD Type

Biology is undergoing a revolution as ‘omic technologies allow us to make hundreds or thousands of measurements on large populations of plants.
  Genetics of inherited cardiovascular disease: Using molecular genetic analysis of cardiovascular disease as a tool to define disease mechanisms and therapeutic targets.
  Prof H Watkins, Prof H Ashrafian, Prof C Redwood, Prof M Farrall
Application Deadline: 24 July 2020

Funding Type

PhD Type

I have had a longstanding focus on inherited heart muscle diseases, in particular hypertrophic cardiomyopathy, which is a relatively common Mendelian condition which puts affected individuals at risk of sudden cardiac death.
  Improved classification of myositis disease subtypes using statistical genetics approaches for stratified medicine
  Dr J Lamb, Dr AM Morris, Dr H Chinoy
Applications accepted all year round

Funding Type

PhD Type

Keywords. idiopathic inflammatory myopathy, myositis, genetics, disease classification, stratified medicine. Idiopathic inflammatory myopathies (IIM) are heterogeneous autoimmune diseases characterized by inflammation of skeletal muscle (myositis).
  Understanding disease mechanisms in autoimmune inflammatory muscle disease
  Dr J Lamb, Dr H Chinoy
Applications accepted all year round

Funding Type

PhD Type

The idiopathic inflammatory myopathies are a spectrum of rare autoimmune disorders characterized by inflammation of muscle tissue (myositis), which leads to muscle weakness and fatigue, and heterogeneous systemic organ involvement.
  Functional coronary artery disease genetics - Defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models
  Dr G Douglas, Prof K Channon
Application Deadline: 24 July 2020

Funding Type

PhD Type

Despite significant advancements in its treatment coronary artery disease is the leading cause of death in both the UK and world wide, accounting for over 66,000 deaths in the UK each year.
  Modelling the spread and control of livestock and zoonotic infectious diseases
  Assoc Prof M Tildesley, Dr E Gorsich, Prof M Keeling
Application Deadline: 7 June 2020

Funding Type

PhD Type

Mathematical models are extensively used in both public-health and veterinary-health policy planning. Modern predictive models are now at the heart of policy decisions, and such models are having an increasing role in supporting decisions associated with livestock infections.
  Genome association studies to detect genetic determinants of virulence traits of invasive meningococcal disease isolates with age stratification
  Dr C D Bayliss
Applications accepted all year round

Funding Type

PhD Type

Neisseria meningitidis is the major cause of bacterial meningitis but is also widespread as an asymptomatic coloniser of human oropharyngeal tissues.
  Human liver fat metabolism and metabolic disease: Understanding the underlying causes and mechanistic basis for intrahepatic fat storage to identify ways of preventing and treating fatty liver disease.
  Prof L Hodson, Dr K Pinnick, Dr S Parry
Application Deadline: 24 July 2020

Funding Type

PhD Type

Understanding the underlying causes and mechanistic basis for intrahepatic fat storage to identify ways of preventing and treating fatty liver disease.
  Understanding the functional role of the non-coding genome in cardiovascular disease
  Prof N Bobola, Prof N Hanley
Applications accepted all year round

Funding Type

PhD Type

Cardiovascular disease is the leading cause of death worldwide. Inherited DNA sequence variants contribute to human diseases and susceptibility.
  Using Statistical Techniques in Genetic Epidemiology to Investigate the Developmental Origins of Health and Disease (DOHaD)
  Prof D Evans
Applications accepted all year round

Funding Type

PhD Type

There is a well-documented observational relationship between low birthweight infants and increased risk of disease in later life (e.g.
  Ca2+ signalling in neurodegeneration and Alzheimer’s disease
  Research Group: School of Biology
  Prof I A Hope
Applications accepted all year round

Funding Type

PhD Type

Human variants of the ryanodine receptor, the main intracellular calcium ion channel, could be responsible for Alzheimer’s disease.
  The phenotypic and functional identification of angiogenic T-cells for potential use to treat cardiovascular disease Project ID SAS0043
  Dr M Ross, Dr G Wright
Application Deadline: 31 May 2020

Funding Type

PhD Type

PROJECT DESCRIPTION. This project is based within the School of Applied Sciences at Edinburgh Napier University and is led by Dr.
  Understanding resistance and tolerance to chytrid fungal disease in amphibians to improve conservation
  Dr L Grogan
Applications accepted all year round

Funding Type

PhD Type

This PhD project will involve working with captive animals (Australian barred frogs and tadpoles, including the endangered Fleay’s barred frog) to understand host responses to infection and mechanisms of resistance and tolerance to the devastating fungal disease, frog chytridiomycosis.
  Investigating the link between amyloid-β oligomers, neuroinflammation and cognitive deficits in preclinical models for Alzheimer’s Disease
  Dr M Harte, Prof J Neill
Applications accepted all year round

Funding Type

PhD Type

Currently four out of the five pharmacological treatments used for Alzheimer’s disease (AD) are acetylcholinesterase inhibitors aimed at boosting the amount of acetylcholine in the brain, with the fifth being an N-methyl-D-aspartate (NMDA) receptor antagonist.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.